CONNECT WITH US
Web3 & Blockchain

Web3 & Blockchain

NFLX Price Prediction: Analyst Target Cuts Compound Technical Weakness as Contract Slips Below $66

Blockchain.News logo

Published on

Add as a preferred source on Google
NFLX Price Prediction: Analyst Target Cuts Compound Technical Weakness as Contract Slips Below $66

Four brokerages trimmed their price targets on Netflix's Nasdaq-listed shares in the wake of the company's third-quarter earnings announcement, and the Binance-listed tokenized contract has followe...

Market analysis includes conditional scenarios, not assured price outcomes or investment advice. Check the data, assumptions and dates cited.

Within a 24-hour window spanning October 21–22, 2026, four separate brokerages revised their price targets on Netflix's Nasdaq-listed NFLX shares downward following the company's third-quarter earnings announcement. The breadth of the reductions is notable: Bank of America lowered its target from $105 to $90 while retaining a Buy rating, citing attractive valuation despite concerns about engagement and slowing growth, per Yahoo Finance. Doug Anmuth at JPMorgan trimmed from $85 to $81 while maintaining Overweight, according to StreetInsider. Sean Diffley at Morgan Stanley cut from $80 to $77 with an Overweight rating, as reported by Benzinga. Barton Crockett at Rosenblatt Securities moved from $75 to $71 with a Neutral stance, explicitly citing slowing growth and limited evidence for a substantially higher sustained growth rate, also per Benzinga.

These are targets on the underlying Nasdaq-listed equity and represent forward estimates at unspecified horizons, not calibrated short-term forecasts. They are not directly tied to the Binance tokenized contract's pricing mechanics. What the cluster of reductions does establish is a clear directional shift in analyst sentiment toward the underlying company: even the most constructive target in the supplied evidence now sits at $90, down from $105 just days prior.

71. 99 million on Binance futures. This is a distinct instrument from the Nasdaq-listed equity, and price differences between the two should be treated accordingly — the analyst targets cited above apply to the underlying equity, not this contract.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.